search
Back to results

One-layer Versus Two-layer Duct-to-mucosa Pancreaticojejunostomy After Pancreaticoduodenectomy

Primary Purpose

Pancreatic Fistula

Status
Unknown status
Phase
Phase 3
Locations
China
Study Type
Interventional
Intervention
pancreaticojejunostomy
Sponsored by
The Second Hospital of Anhui Medical University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Pancreatic Fistula focused on measuring postoperative pancreatic fistula, postoperative hospital stay time, anastomosis time, reoperation rate, morbidity, pancreaticojejunostomy, pancreaticoduodenectomy

Eligibility Criteria

18 Years - 80 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Both male and female, aged 18 to 80;
  • Patients scheduled to undergo pancreaticoduodenectomy;
  • Provided written informed consent;

Exclusion criteria:

  • Patients with severe cardiopulmonary disorder that might prolong the postoperative hospital stay;
  • Patients who had a previous pancreatic operation;
  • Patients with an immunodeficiency;
  • Patients who underwent an emergency operation;
  • Pregnant patients.

Sites / Locations

  • the Second Affiliated Hospital of Anhui Medical UniversityRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

one-layer duct-to-mucosa anastomosis

two-layer duct-to-mucosa anastomosis

Arm Description

one-layer duct-to-mucosa anastomosis is used for pancreaticojejunostomy after pancreaticoduodenectomy.

two-layer duct-to-mucosa anastomosis is used for pancreaticojejunostomy after pancreaticoduodenectomy.

Outcomes

Primary Outcome Measures

postoperative pancreatic fistula(POPF) rate
drainage of any measurable volume of fluid with an amylase content >3 times the upper normal serum value on or after postoperative day 3.

Secondary Outcome Measures

Duration of postoperative hospital stay
Time from day of operation to day of discharge
anastomosis time
anastomosis time was calculated from begining to the end of pancreaticojejunostomy
reoperation rate
The secondary endpoint will be the reoperation rate
Morbidity
the severity of complications was graded according to the Clavien-Dindo classification
Mortality
operative mortality was defined as any death resulting from a complication during surgery
Biliary leakage
biliary leakage was documented in line with the International Study Group of Liver Surgery(ISGLS) definitions and grading systems
Blood transfusion
Administration of blood transfusions is documented for the intraoperative and postoperative period until 48 hours postoperatively

Full Information

First Posted
July 23, 2015
Last Updated
August 16, 2015
Sponsor
The Second Hospital of Anhui Medical University
Collaborators
The First Affiliated Hospital of Anhui Medical University
search

1. Study Identification

Unique Protocol Identification Number
NCT02511951
Brief Title
One-layer Versus Two-layer Duct-to-mucosa Pancreaticojejunostomy After Pancreaticoduodenectomy
Official Title
A Prospective Randomized Clinical Trial of Two Surgical Techniques for Pancreaticojejunostomy in Patients Undergoing Pancreaticoduodenectomy: One-layer Versus Two-layer Duct-to-mucosa Pancreaticojejunostomy
Study Type
Interventional

2. Study Status

Record Verification Date
August 2015
Overall Recruitment Status
Unknown status
Study Start Date
August 2015 (undefined)
Primary Completion Date
December 2018 (Anticipated)
Study Completion Date
December 2018 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
The Second Hospital of Anhui Medical University
Collaborators
The First Affiliated Hospital of Anhui Medical University

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The aim of this study is to investigate a new pancreaticojejunal (PJ) anastomosis procedure named "One-layer duct-to-mucosa pancreaticojejunostomy" in pancreatoduodenectomy, which could provide a feasible option to pancreatic surgeons for patients with pancreaticoduodenectomy.
Detailed Description
Pancreaticoduodenectomy is a standard surgical approach for resectable pancreatic tumors and periampullary tumors. It is considered a safe procedure resulting from the continuous improvement in surgical techniques over the years. Although postoperative mortality has obviously decreased, pancreatic fistula is still a major challenge in pancreatic surgery and remains the major cause of postoperative morbidity and mortality after pancreaticoduodenectomy(PD), ranging from 3% to 30%. Many risks factors have been shown to cause pancreatic fistula(PF) after the operation, including advanced age, prolonged operation time, intraoperative hemorrhage, BMI, soft pancreas, size of the main pancreatic duct and texture of the remnant pancreas. Among them, soft pancreatic texture without a dilated main pancreatic duct is regarded as the most important risk factor in predicting pancreatic fistula. The serious consequences of pancreatic fistula result from the pancreatic juice becoming activated by the bile and intestinal fluid, which will eventually corrupt the PJ anastomosis and the surrounding normal tissues. The corrosion of the vasculature will lead to lethal hemorrhage, which is the main cause of mortality after pancreaticoduodenectomy. Furthermore, pancreatin, together with the bacteria in the alimentary tract, will lead to intra-abdominal infection and abscess. To reduce the pancreatic fistula rate, several techniques have been described as alternatives to the conventional PJ anastomosis. Duct-to-mucosa sutures, binding pancreaticojejunostomy and end-to-side invaginated fashion are widely used in the current clinical setting. Some non-randomized studies showed that the one-layer duct-to-mucosa method was a relatively safe approach. However, the prospective clinical study found that in comparison with the conventional two-layer duct-to-mucosa did obviously decrease the incidence of pancreatic fistula as well as other operative complications. The postoperative pancreatic fistula (POPF), which determines postoperative mortality, length of hospital stay, is dependent of its definition, and is reported in up to 16% of patients. The purpose of this study is to determine whether the new anastomosis called " one-layer duct-to-mucosa " pancreaticojejunostomy can reduce the POPF rate and downgrade compared with the common accepted duct-to-mucosa pancreaticojejunostomy after pancreaticoduodenectomy. This single-centre, open, randomized controlled trail is conducted following International Study Group on Pancreatic Fistula (ISGPF) criteria for pancreatic fistula (PF). The primary endpoint is the POPF rate, and others include overall postoperative complication rate and their severity reoperation rate and hospital stay.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Pancreatic Fistula
Keywords
postoperative pancreatic fistula, postoperative hospital stay time, anastomosis time, reoperation rate, morbidity, pancreaticojejunostomy, pancreaticoduodenectomy

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Single Group Assignment
Masking
Participant
Allocation
Randomized
Enrollment
114 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
one-layer duct-to-mucosa anastomosis
Arm Type
Experimental
Arm Description
one-layer duct-to-mucosa anastomosis is used for pancreaticojejunostomy after pancreaticoduodenectomy.
Arm Title
two-layer duct-to-mucosa anastomosis
Arm Type
Active Comparator
Arm Description
two-layer duct-to-mucosa anastomosis is used for pancreaticojejunostomy after pancreaticoduodenectomy.
Intervention Type
Procedure
Intervention Name(s)
pancreaticojejunostomy
Intervention Description
To create the posterior suturing layers, the needle is inserted from the posterior interior side of the pancreatic duct, passing through the dorsal region of the parenchyma of the pancreatic stump to the posterior surface of the pancreas approximately 0.5 cm distal to the cut edge. The other side of the needle starts from the inside of the jejunum lumen to the subserosa and then passes through the seromuscular layer to the posterior surface of the bowel.The anterior suturing layer is performed in the same manner. Two layer anatomosis with "Duct-to-Mucosa" pancreaticojejunostomy is performed by suturing the pancreatic parenchyma to the jejunal seromuscular layer and no stenting tube was used.
Primary Outcome Measure Information:
Title
postoperative pancreatic fistula(POPF) rate
Description
drainage of any measurable volume of fluid with an amylase content >3 times the upper normal serum value on or after postoperative day 3.
Time Frame
30 days
Secondary Outcome Measure Information:
Title
Duration of postoperative hospital stay
Description
Time from day of operation to day of discharge
Time Frame
30 days
Title
anastomosis time
Description
anastomosis time was calculated from begining to the end of pancreaticojejunostomy
Time Frame
1 hour
Title
reoperation rate
Description
The secondary endpoint will be the reoperation rate
Time Frame
30 days
Title
Morbidity
Description
the severity of complications was graded according to the Clavien-Dindo classification
Time Frame
30 days
Title
Mortality
Description
operative mortality was defined as any death resulting from a complication during surgery
Time Frame
30 days
Title
Biliary leakage
Description
biliary leakage was documented in line with the International Study Group of Liver Surgery(ISGLS) definitions and grading systems
Time Frame
30
Title
Blood transfusion
Description
Administration of blood transfusions is documented for the intraoperative and postoperative period until 48 hours postoperatively
Time Frame
2 days

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Both male and female, aged 18 to 80; Patients scheduled to undergo pancreaticoduodenectomy; Provided written informed consent; Exclusion criteria: Patients with severe cardiopulmonary disorder that might prolong the postoperative hospital stay; Patients who had a previous pancreatic operation; Patients with an immunodeficiency; Patients who underwent an emergency operation; Pregnant patients.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
xiaoping geng, professor
Phone
86+13956010132
Email
xp_geng@163.net
First Name & Middle Initial & Last Name or Official Title & Degree
shubo pan, master
Phone
86+15856943673
Email
aydpanshubo@126.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
xiaoping geng, professor
Organizational Affiliation
the vice President of the second affiliated hospitalof Anhui medical university
Official's Role
Principal Investigator
Facility Information:
Facility Name
the Second Affiliated Hospital of Anhui Medical University
City
Hefei
State/Province
Anhui
ZIP/Postal Code
230022
Country
China
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Geng Xiaoping
Phone
86+13956010132
Email
xp_geng@163.net
First Name & Middle Initial & Last Name & Degree
shubo pan
Phone
86+15856943673
Email
aydpanshubo@126.com

12. IPD Sharing Statement

Citations:
PubMed Identifier
25840535
Citation
Zhang L, Li Z, Wu X, Li Y, Zeng Z. Sealing pancreaticojejunostomy in combination with duct parenchyma to mucosa seromuscular one-layer anastomosis: a novel technique to prevent pancreatic fistula after pancreaticoduodenectomy. J Am Coll Surg. 2015 May;220(5):e71-7. doi: 10.1016/j.jamcollsurg.2014.12.047. Epub 2015 Jan 15. No abstract available.
Results Reference
result
PubMed Identifier
26037262
Citation
Wei J, Liu X, Wu J, Xu W, Zhou J, Lu Z, Chen J, Guo F, Gao W, Li Q, Jiang K, Dai C, Miao Y. Modified One-layer Duct-to-mucosa Pancreaticojejunostomy Reduces Pancreatic Fistula After Pancreaticoduodenectomy. Int Surg. 2015 Jun 3. doi: 10.9738/INTSURG-D-15-00094.1. Online ahead of print.
Results Reference
result
PubMed Identifier
25682724
Citation
El Nakeeb A, El Hemaly M, Askr W, Abd Ellatif M, Hamed H, Elghawalby A, Attia M, Abdallah T, Abd ElWahab M. Comparative study between duct to mucosa and invagination pancreaticojejunostomy after pancreaticoduodenectomy: a prospective randomized study. Int J Surg. 2015 Apr;16(Pt A):1-6. doi: 10.1016/j.ijsu.2015.02.002. Epub 2015 Feb 13. Erratum In: Int J Surg. 2018 Mar 21;:
Results Reference
result
PubMed Identifier
27530630
Citation
Pan SB, Geng W, Zhou DC, Chen JM, Zhao HC, Liu FB, Xie SX, Hou H, Zhao YJ, Xie K, Wang GB, Geng XP. One-layer versus two-layer duct-to-mucosa pancreaticojejunostomy after pancreaticoduodenectomy: study protocol for a randomized controlled trial. Trials. 2016 Aug 17;17(1):407. doi: 10.1186/s13063-016-1517-8.
Results Reference
derived

Learn more about this trial

One-layer Versus Two-layer Duct-to-mucosa Pancreaticojejunostomy After Pancreaticoduodenectomy

We'll reach out to this number within 24 hrs